Investors' Soapbox AM

M&A May Pop Up in Drug Distribution

Raymond James cites an expectation for accelerating growth in 2014.

August 15, 2013

Raymond James & Associates

A review of the Wolters Kluwer pharmaceutical data indicated that underlying prescription growth, excluding calendar shifts, continued to trend positively during the month of July, a continuation of the theme we have seen throughout most of 2013, with script growth certainly more resilient than the rest of the health-care channel year-to-date.